Immunome, Inc.
IMNMNASDAQNASDAQ Capital Market·USD·Closed
$24.62
−$0.45 (1.79%)
$24.62
−$0.45 (1.79%)
Not investment advice.Learn more
Immunome, Inc. presents a mixed picture — bulls and bears both have arguments.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Mid-cap company
P/E Ratio
Div Yield
No dividend